Loading...
Loading...
India's vancomycin imports from UNITED STATES total $74.8K across 74 shipments from 15 foreign suppliers. NEWLIFE MEDICALS (USA). INC. leads with $29.7K in import value; the top 5 suppliers together control 78.0% of this origin. Leading Indian buyers include AUROBINDO PHARMA LTD. This corridor reflects India's pharmaceutical import demand for vancomycin — a diversified sourcing base with multiple active suppliers from UNITED STATES.

NEWLIFE MEDICALS (USA). INC. is the leading Vancomycin supplier from UNITED STATES to India, with import value of $29.7K across 1 shipments. The top 5 suppliers — NEWLIFE MEDICALS (USA). INC., AGRACE PHARMA, AZURITY PHARMACEUTICALS, ESPEE BIOPHARMA & FINECHEM LLC, SUTPHIN DRUGS INC — collectively account for 78.0% of total import value from this origin.
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | NEWLIFE MEDICALS (USA). INC. | $29.7K | 1 | 39.7% |
| 2 | AGRACE PHARMA | $12.0K | 17 | 16.1% |
| 3 | AZURITY PHARMACEUTICALS | $6.3K | 1 | 8.4% |
| 4 | ESPEE BIOPHARMA & FINECHEM LLC | $5.4K | 7 | 7.2% |
| 5 | SUTPHIN DRUGS INC | $4.9K | 1 | 6.6% |
| 6 | ESPEE BIOPHARMA AND FINECHEM LLC | $3.5K | 2 | 4.7% |
| 7 | SPRING BIO SOLUTION | $3.0K | 7 | 4.0% |
| 8 | ESPEE BIOPHARMA FINECHEM LLC | $1.4K | 3 | 1.8% |
| 9 | HOSPIRA A PFIZER COMPANY | $1.1K | 2 | 1.4% |
| 10 | HOSPIRA, A PFIZER COMPANY. | $1.0K | 1 | 1.4% |
| 11 | BILCARE GCS INC | $1.0K | 3 | 1.3% |
| 12 | SBV PHARMACY CORP | $939 | 6 | 1.3% |
| 13 | E-PHARM LLC | $906 | 1 | 1.2% |
| 14 | ESPEE BIOPHARMA & FINECHEM LLC. | $896 | 4 | 1.2% |
| 15 | AMSTERDAM PHARMA | $707 | 1 | 0.9% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | AUROBINDO PHARMA LTD | $29.7K | 1 | 39.7% |
| 2 | ALEMBIC PHARMACEUTICALS LIMITED | $9.2K | 10 | 12.2% |
| 3 | STERISCIENCE SPECIALTIES PRIVATE LIMITED | $8.6K | 9 | 11.5% |
| 4 | LUPIN LIMITED | $8.3K | 9 | 11.1% |
| 5 | SLAYBACK PHARMA INDIA LLP | $6.3K | 1 | 8.4% |
| 6 | ALKEM LABORATORIES LIMITED | $3.2K | 5 | 4.3% |
| 7 | PFIZER HEALTHCARE INDIA PRIVATE LIMITED | $2.4K | 4 | 3.3% |
| 8 | EXTROVIS PRIVATE LIMITED | $2.3K | 8 | 3.1% |
| 9 | AMNEAL PHARMACEUTICALS PRIVATE LIMITED | $1.3K | 5 | 1.7% |
| 10 | GLAND PHARMA LTD | $1.1K | 2 | 1.5% |
| 11 | SYMBIOTEC PHARMALAB PRIVATE LIMITED | $1.0K | 3 | 1.3% |
| 12 | PRATHYAK LABORATORIES PRIVATE LIMITED | $939 | 6 | 1.3% |
| 13 | CNOIC LIFE SCIENCES LLP | $301 | 3 | 0.4% |
| 14 | NOVITIUM LABS PRIVATE LIMITED | $45 | 7 | 0.1% |
| 15 | EUGIA PHARMA SPECIALITIES LIMITED | $37 | 1 | 0.0% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Vancomycin suppliers from UNITED STATES to India include NEWLIFE MEDICALS (USA). INC., AGRACE PHARMA, AZURITY PHARMACEUTICALS. The leading supplier is NEWLIFE MEDICALS (USA). INC. with import value of $29.7K USD across 1 shipments. India imported Vancomycin worth $74.8K USD from UNITED STATES in total across 74 shipments.
India imported Vancomycin worth $74.8K USD from UNITED STATES across 74 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Vancomycin sourced from UNITED STATES include AUROBINDO PHARMA LTD, ALEMBIC PHARMACEUTICALS LIMITED, STERISCIENCE SPECIALTIES PRIVATE LIMITED. The largest buyer is AUROBINDO PHARMA LTD with $29.7K in imports across 1 shipments.
The total value of Vancomycin imports from UNITED STATES to India is $74.8K USD, across 74 shipments and 15 foreign suppliers. Data source: Indian Customs (DGFT).
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
74 Verified Shipments
15 suppliers, 15 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists